COVID-19 pandemic
The U.S. CDC announces that it has recommended the Novavax COVID-19 vaccine for use in children between the ages of 12 and 17 years.
Sources: CNET
Changes
- The U.S. CDC announces that it has recommended the Novavax COVID-19 vaccine for youths between the ages of 12 and 17.
- The U.S. CDC announces that it has recommended the Novavax COVID-19 vaccine for children between the ages of 12 and 17 years.
- The U.S. CDC announces that it has recommended the Novavax COVID-19 vaccine for use in children between the ages of 12 and 17 years.